Examining medicine shortages and their consequences through economic, clinical, and economic lens
A study on medicine shortages in the Netherlands found that disease and costs were the two most affected elements, with 30% and 20% of shortages rated high on these elements, respectively. The study used a framework of economic, clinical, and patient outcomes to assess the impact of medicine shortages on patients. Direct impact, represented by alternative product and disease, was rated high for 30% of the shortages, while indirect impact, represented by costs, susceptibility, and number of patients, was rated high for 17% of the shortages. No significant differences in impact scores were found based on product characteristics.
Recent Posts
Regulatory Expansion of OTC Glucose Monitoring for Children
The FDA has cleared the first over-the-counter continuous glucose monitor for children as young as two who do not use insulin, establishing OTC Glucose Monitoring Children as a practical new option for families. This
FDA Medical Device Exemptions for Low-Risk Unclassified Products
The FDA Medical Device Exemptions target specific unclassified preamendment devices that present minimal risk to patients. By exercising enforcement discretion, the agency no longer expects manufacturers to submit 510(k) premarket notification applications for these products until a formal exempt...
Navigating Medtech Reimbursement Strategies for Successful Innovation
Successful medtech reimbursement strategies must be developed in parallel with regulatory approval, because clearance only confirms safety and efficacy while payers separately decide financial coverage. Investors now routinely demand evidence of sustainable payment pathways long before regulatory...